Literature DB >> 18327972

Reactive oxygen and reactive nitrogen as signaling molecules for caspase 3 activation in acute cardiac transplant rejection.

Galen M Pieper1, Vani Nilakantan, Thanh K Nguyen, Gail Hilton, Allan M Roza, Christopher P Johnson.   

Abstract

Apoptosis is a significant factor in cardiac dysfunction and graft failure in cardiac rejection. In this study, we examined potential signaling molecules responsible for caspase 3 activation in a model of acute cardiac allograft rejection. The roles of reactive oxygen species (ROS) and nitric oxide (NO) were determined in untreated allografts and allograft recipients treated with either cyclosporine (CsA), alpha-phenyl-t-butylnitrone (PBN, a spin-trapping agent), vitamin C (VitC), Mn(III)tetrakis (1-methyl-4-pyridyl)porphyrin); MnTmPyP, a superoxide dismutase (SOD) mimetic), or L-(1-iminoethyl)lysine) (L-NIL), an inhibitor of inducible NO synthase (iNOS) enzyme activity. Graft tissue was taken for measuring superoxide radical production, Western blotting, and direct measurement of caspase 3 activity. Activation of caspase 3 in untreated allografts was revealed by the appearance of cleaved caspase 3 from pro-caspase 3 by Western blotting and functional caspase 3 catalytic activity. CsA or PBN inhibited iNOS expression and caspase 3 activity. VitC and MnTmPyP did not alter iNOS expression or decrease NO levels but did inhibit caspase 3 activity. In contrast, L-NIL completely inhibited the increase in NO production without altering iNOS expression and inhibited caspase 3 activity. The prevention of TUNEL staining by MnTmPyP and L-NIL confirmed downstream effects of superoxide and NO on apoptosis. These studies indicate that both superoxide and NO (precursors of peroxynitrite formation) play a significant role in caspase 3 activation in cardiac allograft rejection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327972      PMCID: PMC2424137          DOI: 10.1089/ars.2007.1867

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  34 in total

Review 1.  Nitric oxide: NO apoptosis or turning it ON?

Authors:  Bernhard Brüne
Journal:  Cell Death Differ       Date:  2003-08       Impact factor: 15.828

2.  Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection.

Authors:  Matthias J Szabolcs; Ji Sun; Ningsheng Ma; Arline Albala; Robert R Sciacca; Gary B Philips; John Parkinson; Niloo Edwards; Paul J Cannon
Journal:  Circulation       Date:  2002-10-29       Impact factor: 29.690

3.  Antioxidant treatment inhibits activation of myocardial nuclear factor kappa B and inhibits nitrosylation of myocardial heme protein in cardiac transplant rejection.

Authors:  G M Pieper; C Olds; G Hilton; P F Lindholm; M B Adams; A M Roza
Journal:  Antioxid Redox Signal       Date:  2001-02       Impact factor: 8.401

4.  Protective mechanisms of a metalloporphyrinic peroxynitrite decomposition catalyst, WW85, in rat cardiac transplants.

Authors:  Galen M Pieper; Vani Nilakantan; Min Chen; Jing Zhou; Ashwani K Khanna; James D Henderson; Christopher P Johnson; Allan M Roza; Csaba Szabó
Journal:  J Pharmacol Exp Ther       Date:  2005-03-22       Impact factor: 4.030

5.  Regulation of inducible nitric oxide synthase by rapid cellular turnover and cotranslational down-regulation by dimerization inhibitors.

Authors:  Pawel J Kolodziejski; Ja-Seok Koo; N Tony Eissa
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

6.  Zinc-mediated reduction of apoptosis in cardiac allografts.

Authors:  M H Kown; T Van der Steenhoven; F G Blankenberg; G Hoyt; G J Berry; J F Tait; H W Strauss; R C Robbins
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

7.  Inhibition of nitrosylation, nitration, lymphocyte proliferation, and gene expression in acute and delayed cardiac allograft rejection by an orally active dithiocarbamate.

Authors:  Galen M Pieper; Ashwani K Khanna; Bal N Kampalath; Christopher C Felix; Gail Hilton; Christopher P Johnson; Mark B Adams; Allan M Roza
Journal:  J Cardiovasc Pharmacol       Date:  2004-04       Impact factor: 3.105

8.  Attenuated acute cardiac rejection in NOS2 -/- recipients correlates with reduced apoptosis.

Authors:  J Koglin; D J Granville; T Glysing-Jensen; J S Mudgett; C M Carthy; B M McManus; M E Russell
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

9.  Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.

Authors:  A Djamali; J S Odorico
Journal:  Transplantation       Date:  1998-12-27       Impact factor: 4.939

10.  Effects of inhibition of poly(adenosine diphosphate-ribose) synthase on acute cardiac allograft rejection.

Authors:  Yulin Liu; Ni Huiping Son; Matthias J Szabolcs; Ninsheng Ma; Robert R Sciacca; Arline Albala; Niloo Edwards; Paul J Cannon
Journal:  Transplantation       Date:  2004-09-15       Impact factor: 4.939

View more
  5 in total

Review 1.  Aging and inflammation: etiological culprits of cancer.

Authors:  Aamir Ahmad; Sanjeev Banerjee; Zhiwei Wang; Dejuan Kong; Adhip P N Majumdar; Fazlul H Sarkar
Journal:  Curr Aging Sci       Date:  2009-12

2.  Oxazine conjugated nanoparticle detects in vivo hypochlorous acid and peroxynitrite generation.

Authors:  Peter Panizzi; Matthias Nahrendorf; Moritz Wildgruber; Peter Waterman; Jose-Luiz Figueiredo; Elena Aikawa; Jason McCarthy; Ralph Weissleder; Scott A Hilderbrand
Journal:  J Am Chem Soc       Date:  2009-11-04       Impact factor: 15.419

3.  Sepiapterin decreases acute rejection and apoptosis in cardiac transplants independently of changes in nitric oxide and inducible nitric-oxide synthase dimerization.

Authors:  Galen M Pieper; Irina A Ionova; Brian C Cooley; Raymond Q Migrino; Ashwani K Khanna; Jennifer Whitsett; Jeannette Vásquez-Vivar
Journal:  J Pharmacol Exp Ther       Date:  2009-03-23       Impact factor: 4.030

4.  Human myocardial mitochondrial oxidative capacity is impaired in mild acute heart transplant rejection.

Authors:  Daniel Scheiber; Elric Zweck; Sophie Albermann; Tomas Jelenik; Maximilian Spieker; Florian Bönner; Patrick Horn; Heinz-Peter Schultheiss; Ganna Aleshcheva; Felicitas Escher; Udo Boeken; Payam Akhyari; Michael Roden; Malte Kelm; Julia Szendroedi; Ralf Westenfeld
Journal:  ESC Heart Fail       Date:  2021-09-06

Review 5.  Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries.

Authors:  George D Bittner; Jared S Bushman; Cameron L Ghergherehchi; Kelly C S Roballo; Jaimie T Shores; Tyler A Smith
Journal:  J Neuroinflammation       Date:  2022-02-28       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.